PDUFA/Drug Safety Bill Moves Toward Senate Floor
This article was originally published in The Pink Sheet Daily
Executive Summary
Revisions to DTC and pediatric sections seem possible after ranking member Enzi supports two failed amendments.
You may also be interested in...
Follow-On Biologics, Drug Importation Get Split Decision From Bush Administration
Memo on potential amendments to FDA Revitalization Act threatens veto if importation provisions are attached and expresses concern about a generic biologic pathway but does not declare it unacceptable.
Follow-On Biologics, Drug Importation Get Split Decision From Bush Administration
Memo on potential amendments to FDA Revitalization Act threatens veto if importation provisions are attached and expresses concern about a generic biologic pathway but does not declare it unacceptable.
Pediatric Exclusivity Incentive Limited Under Draft PDUFA Bill
Products with more than $1 billion in sales would only get three months, and awards would only be given after labeling changes are made.